Arteriovenous Malformation (AVM) Diagnosis
Arteriovenous Malformation (AVM) Diagnosis
Finding an AVM is easy. Describing it well enough to decide what to do is not, and the two are done with different tests. MRI and MR angiography will show the malformation and, critically, will show where it sits in relation to the brain around it. But the study that the plan is actually built on is catheter angiography, because it is the only one that resolves the sequence: which arteries feed the malformation, how the nidus fills, and where the blood goes afterwards. Without that sequence, a surgeon cannot say whether the lesion can be removed; with it, three numbers can be assigned, and their sum is what the whole conversation turns on.
MRI and MR angiography: finding it, and seeing the surroundings
For a malformation that has not bled, MRI with MR angiography is usually the first study that shows it properly. It demonstrates the nidus, the flow voids of the enlarged feeding arteries and draining veins, and — the part that CT cannot do — the relationship between the malformation and the brain around it.
MRI also answers a question the patient often cannot. Old blood products, seen as a rim of haemosiderin on susceptibility sequences, are evidence of a bleed that happened at some point without the patient noticing. Finding them moves a malformation from the unruptured column into one that has bled, and that changes the risk being discussed. It is one of the more consequential single lines in a report.
The limitation of MRI is resolution in time. An MR angiogram is a snapshot, and a snapshot of a tangle of vessels is genuinely difficult to read: it cannot reliably separate an artery that fills early from a vein that fills late. For that, catheter angiography is needed.
Catheter angiography: why it is still the reference
Digital subtraction angiography is an invasive study, performed by the team that would carry out the treatment, and it remains the reference for four decades on for one reason: it shows the vessels filling in time rather than as a single picture. Feeding arteries, nidus, and draining veins appear in sequence, and that sequence is the anatomy.
It settles the questions that decide treatment. Which arteries feed the nidus, and are there vessels passing through the same region that supply normal brain and must be preserved? Is the nidus compact or diffuse? Is there a single draining vein or several, and does any of them pass through the deep system? Each of these is a matter of timing as much as of shape, which is why a static study cannot replace it.
It is also the study from which endovascular treatment proceeds, and it is usually done with the intention of treating rather than purely of looking. Patients should expect it to be discussed in those terms, and should expect the team performing it to be the team that would carry out whatever follows.
The grade: three numbers that decide the technique
The scale used most widely assigns points in three categories. Size of the nidus: under 3 cm scores one, 3–6 cm scores two, above 6 cm scores three. Eloquence of the adjacent brain: one point if the malformation sits next to cortex serving language, movement, vision or sensation. Venous drainage: one point if any of it passes through the deep venous system.
Added together, the total runs from one to five, and it is used as shorthand for a much longer discussion. Low-grade malformations — the ones that are small, superficial and away from eloquent cortex — are the ones where surgery is curative and carries a risk lower than the lifetime risk of leaving them. High-grade ones are the ones where the risk of removal is high enough that radiosurgery, embolisation, or nothing at all enters the conversation.
Two cautions about the number. It was designed to estimate surgical risk, not to predict bleeding, and it is not a good predictor of haemorrhage — a small malformation can bleed. And it is a summary, not a decision: two malformations with the same total can be different operations, and supplementary features such as a diffuse nidus or perforating-artery supply are the reason a specialist reads the images rather than the score.
Looking for a second lesion: associated aneurysms
A proportion of patients with an AVM also have an aneurysm — on a feeding artery, inside the nidus, or on an unrelated vessel. They are thought to form because the vessels carrying the increased flow are exposed to it for years. A report on an AVM should state whether one was looked for, and what was found.
This matters most after a bleed, because the aneurysm may be the source rather than the nidus. The two are treated differently: an aneurysm is sealed by coiling or clipping, usually urgently and usually by a different route from the malformation itself. Identifying which lesion bled is not an academic question when the patient is in front of you with blood on the scan.
It matters in the unruptured case too, though differently. An associated aneurysm is often the lesion that gets treated first, because it can be sealed with a lower risk than anything that could be done about the malformation, and because it is a separate source of bleeding.
Confirming obliteration, and what "cured" means here
Obliteration means that no abnormal vessels fill on an angiogram. It is confirmed on catheter angiography after radiosurgery, and after resection, and it is the only reliable way to say the malformation is gone. MRI can suggest it; an angiogram establishes it.
The timing depends on the technique. After a resection that the surgeon believes to be complete, an angiogram is performed to confirm it. After radiosurgery, nothing is expected to happen quickly: the vessels thicken and close over one to three years, and imaging is repeated at intervals until the study shows no residual filling. During that interval the malformation is still present and can still bleed.
What follows confirmation is narrower than most patients expect. Once obliteration is documented, the yearly risk attributable to the malformation is taken to have been removed — but a patient who has had a seizure may still need anticonvulsants, and a patient who has bled carries the consequences of that bleed rather than of the malformation. Neither of those is undone by the angiogram.
What a report worth having says
A record is ready to be reviewed when it contains more than the diagnosis. What is needed is the imaging itself — MRI and MR angiography, and the catheter angiography if one has been done — with the written reports, plus the operative or radiosurgery record if the malformation has been treated, and a note of any seizure and of the medication being taken for it.
A second opinion is worth having in three situations: when an unruptured malformation has been found and the question of whether to treat has been answered in a single sentence; when a high-grade malformation has been declared untreatable without a discussion of radiosurgery or of staged embolisation; and when treatment has been given and the question of whether obliteration was achieved has not been settled by an angiogram.
Reviews are returned by a neurovascular specialist as a written opinion within about 48 hours of complete records arriving, and the opinion states the grade, which techniques are reasonable here and which are not, whether observation is the better answer, and what remains uncertain. Where the question can be answered from the images alone, a video consultation is usually enough, and a journey is not the first step.